Blood

Oncology & Cancer

Skin cancer harbors targetable mutation

An especially deadly subtype of T-cell lymphoma is distinguished by unique mutations in a specific protein signaling pathway, according to a study published in the journal Blood.

Radiology & Imaging

New imaging method for the detection of gastric lymphomas

A new imaging technique for the detection of MALT lymphomas, malignant tumors of the lymphatic system, could probably save patients numerous gastroscopies. A study group of MedUni Wien achieved a high imaging accuracy by ...

Neuroscience

Cause of neonatal strokes identified

Scientists have discovered an important cause of stroke occurring in the womb or just after birth, paving the way for new treatments.

Oncology & Cancer

Fundamental feature of aggressive lymphomas discovered

Research led by the University of Southampton has revealed a new fundamental feature of aggressive B-cell lymphomas which could open the door to further research into early detection and treatment of the disease.

Oncology & Cancer

Gene implicated in poor skin cancer therapy outcomes

Whole-genome sequencing analysis of cutaneous T-cell lymphomas has revealed that deletions of the gene PD1 were associated with worse prognoses, according to a recent Northwestern Medicine study published in Blood.

Medical research

Combined therapy shows promise for chronic lymphocytic leukemia

A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia (CLL), according to a Northwestern Medicine clinical trial ...

Medical research

Novel treatments to prevent infections in patients with leukemia

Using either universal myeloid progenitor cells or expanded umbilical cord blood transplantation could help prevent infections in patients with leukemia, according to a pair of studies co-authored by Olga Frankfurt, MD, associate ...

Diseases, Conditions, Syndromes

A promising two-punch therapy for Langerhans cell histiocytosis

Langerhans cell histiocytosis (LCH) is a rare cancer involving dendritic cells, a type of white blood cell that usually helps defend against infections. The current standard of care for LCH, chemotherapy, cures fewer than ...

page 10 from 40